Brian K. England, MD

Education

• 1987-1989 / Emory University, Fellowship, Nephrology
• 1987-1988 / Emory University, Chief Medical Resident
• 1983-1986 / Emory University, Residency, Internal Medicine
• 1979-1983 / University of Louisville, Doctor of Medicine
• 1975-1979 / University of Louisville, Bachelor of Science, Zoology

Work Experience

• 1996-Present / Clinical Nephrologist, Mountain Kidney and Hypertension Associates, PA
• 1989-1996 / Associate Professor of Medicine, Emory University School of Medicine
• 1986-1987 / Staff Physician, Georgia Sickle Cell Clinic, Grady Memorial Hospital

Credentials

• Medical License / North Carolina Physician License - 9600527
• Certification / North Carolina Medical Board – 72419
• American Board of Internal Medicine, 1986
• American Board of Nephrology, 2010, 2020

Hospital Affiliations

• Mission-St. Joseph's Health System
• Pardee Memorial Hospital
• Care Partners Rehabilitation Hospital
• Blue Ridge Regional Hospital
• McDowell Hospital
• Transylvania Regional Hospital
• Park Ridge Hospital
• Highlands-Cashiers Regional Hospital
• Angel Medical Center

Professional Affiliations / Committees

• American Society of Nephrology
• Renal Physicians Association
• National Kidney Foundation
• American Society of Hypertension
• 2010-Present / Adjunct Professor, Department of Medicine, UNC School of Medicine, Chapel Hill
• 2006-2015 / Board of Directors, Mission Health Care Systems
• 2007-2013 / Chair of Quality Committee of the Board, Mission Health, Care Systems
• 1999-2006 / Chief of Adult Medicine Service Line, Mission Hospital

Honors and Awards

• Phi Kappa Phi Honor Society
• Woodcock Society
• Alpha Omega Alpha Medical Honor Society
• Best House Officer by Emory School of Medicine, Class of 1988

Research / Grants

• Principal Investigator
  • Veterans Administration Merit Review, Changes in Enzyme Activity and Gene Transcription in Acidosis and Uremia
• Co-Investigator
  • National Institutes of Health - Modification of Diet in Renal Disease
• Sub-Investigator
  • START-CKD: Strategies Using Darbepoetin alfa to Avoid Transfusions in Chronic Kidney Disease
• Sub-Investigator
  • A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis
• Sub-Investigator
  • Open Label Uncontrolled Extension Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis
• Sub-Investigator
  • Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, with MRI Substudy, of Repeated Doses of Ferumoxytol Compared with Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis